MORGAN STANLEY - THE ONCOLOGY INSTITUTE INC ownership

THE ONCOLOGY INSTITUTE INC's ticker is and the CUSIP is 68236X100. A total of 30 filers reported holding THE ONCOLOGY INSTITUTE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of THE ONCOLOGY INSTITUTE INC
ValueSharesWeighting
Q3 2023$7,647
+46.3%
5,462
-42.5%
0.00%
Q2 2023$5,227
-57.2%
9,500
-47.2%
0.00%
Q1 2023$12,206
-59.8%
18,006
-2.2%
0.00%
Q4 2022$30,383
+406.4%
18,414
+1192.2%
0.00%
Q3 2022$6,0000.0%1,425
+18.5%
0.00%
Q2 2022$6,000
-81.8%
1,203
-73.1%
0.00%
Q1 2022$33,000
+266.7%
4,475
+380.2%
0.00%
Q4 2021$9,0009320.00%
Other shareholders
THE ONCOLOGY INSTITUTE INC shareholders Q1 2022
NameSharesValueWeighting ↓
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 1,058,151$582,1950.57%
Triatomic Management LP 904,689$497,5790.51%
Prosight Management, LP 910,604$501,0140.08%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,360,052$1,848,7010.04%
Diametric Capital, LP 128,392$70,6410.03%
Y-Intercept (Hong Kong) Ltd 138,899$76,4220.01%
Saba Capital Management, L.P. 170,378$93,7420.00%
PRELUDE CAPITAL MANAGEMENT, LLC 41,217$22,6780.00%
OLD MISSION CAPITAL LLC 52,740$29,0170.00%
NWAM LLC 20,000$11,0040.00%
View complete list of THE ONCOLOGY INSTITUTE INC shareholders